Data / Form D filings / CND Life Sciences, Inc.
CND Life Sciences, Inc.: Form D filings
CND Life Sciences, Inc., a biotechnology company in Scottsdale, AZ, filed 12 Form D notices with the SEC between 2021 and 2026. The latest, on August 3, 2026, reports $6.3 million sold of a $6.3 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9165 E. DEL CAMINO DRIVE SUITE 101, Scottsdale, AZ, 85258
- Phone
- (617) 223-1585
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1841099
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Amendment | $6,316,514 | $6,316,514 | 14 | Jun 9, 2026 | sec.gov | |
| Jun 16, 2026 | New notice | $6,250,000 | $4,314,750 | $1,935,250 | 1 | Jun 9, 2026 | sec.gov |
| May 6, 2025 | Amendment | $9,000,000 | $8,648,469 | $351,531 | 38 | Feb 28, 2025 | sec.gov |
| Apr 15, 2025 | Amendment | $9,000,000 | $3,664,565 | $5,335,435 | 27 | Feb 28, 2025 | sec.gov |
| Mar 6, 2025 | New notice | $7,500,000 | $3,514,565 | $3,985,435 | 26 | Feb 28, 2025 | sec.gov |
| Mar 27, 2024 | New notice | $6,000,000 | $2,007,000 | $3,993,000 | 22 | Mar 20, 2024 | sec.gov |
| Jul 24, 2023 | New notice | $1,457,000 | $1,457,000 | 19 | Jul 14, 2023 | sec.gov | |
| Mar 24, 2023 | Amendment | $4,500,000 | $4,500,000 | 26 | Sep 16, 2022 | sec.gov | |
| Sep 22, 2022 | New notice | $4,000,000 | $2,545,000 | $1,455,000 | 17 | Sep 16, 2022 | sec.gov |
| Nov 10, 2021 | New notice | $5,000,000 | $4,200,000 | $800,000 | 22 | Oct 29, 2021 | sec.gov |
| Apr 28, 2021 | Amendment | $2,875,000 | $2,875,000 | 20 | Jan 5, 2021 | sec.gov | |
| Jan 20, 2021 | New notice | $2,500,000 | $825,000 | $1,675,000 | 7 | Jan 5, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard J. Morello | Executive Officer, Director | |
| Todd Levine | Executive Officer, Director | |
| Peter Harris | Executive Officer, Director | |
| Enrique Carrazana | Director | |
| Christopher Gibbons | Director | |
| Jack Seaver | Director |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
Every Form D from the week of Aug 3, 2026 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CND Life Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.